TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.350
+0.050 (2.17%)
Aug 14, 2026, 11:30 AM EDT - Market open
TuHURA Biosciences Market Cap
TuHURA Biosciences has a market cap or net worth of $149.65 million as of August 14, 2026. Its market cap has increased by 13.20% in one year.
Market Cap
149.65M
Enterprise Value
143.81M
1-Year Change
13.20%
Ranking
Category
Stock Price
$2.35
ChartMarket Cap Chart
Since October 18, 2024, TuHURA Biosciences's market cap has decreased from $264.60M to $149.65M, a decrease of -43.44%. That is a compound annual growth rate of -26.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 149.65M | 225.71% |
| Dec 31, 2025 | 45.95M | -73.43% |
| Dec 31, 2024 | 172.94M | -34.64% |
| Oct 18, 2024 | 264.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 152.92M |
| Canton Strategic Holdings | 151.93M |
| Kazia Therapeutics | 150.95M |
| Unicycive Therapeutics | 150.42M |
| Molecular Partners AG | 149.11M |
| Humacyte | 148.30M |
| Milestone Pharmaceuticals | 145.57M |
| Cibus | 145.03M |